about
Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.Coffee: A Dietary Intervention on Type 2 Diabetes?Co-expression network analysis and genetic algorithms for gene prioritization in preeclampsiaDislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.First trimester aneuploidy screening program for preeclampsia prediction in a portuguese obstetric population.Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis.Preeclampsia prediction and management.Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord bloodSimilarities between pre-eclampsia and atherosclerosis: a protective effect of physical exercise?Consensus strategy in genes prioritization and combined bioinformatics analysis for preeclampsia pathogenesisLipid levels including oxidized LDL in women with history of preeclampsia.Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptor.Erythrocyte damage and leukocyte activation in ischemic stroke.Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.Band 3 as a marker of erythrocyte changes in pregnancy.Apolipoprotein E and cholesteryl ester transfer protein polymorphisms in normal and preeclamptic pregnancies.Characterization of beta-lactamases encoded by pathogenic strains of Escherichia coli from Portugal.Erythrocyte damage in mild and severe psoriasis.LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study.Altered alanine aminotransferase and gamma-glutamyl transpeptidase in women with history of preeclampsia: association with waist-to-hip ratio and body mass index.Haemostatic factors in women with history of preeclampsia.Fetal lipoprotein changes in pre-eclampsia.Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size.Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage.The inflammatory response in mild and in severe psoriasis.Neutrophil activation and C-reactive protein concentration in preeclampsia.The effect of green tea in oxidative stress.Artificial neural network for normal, hypertensive, and preeclamptic pregnancy classification using maternal heart rate variability indexes.Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis.Unravelling the relationship between protein sequence and low-complexity regions entropies: Interactome implicationsSerum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosisAre we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis?Lipid profile changes by high activity anti-retroviral therapyFetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancyPre-eclampsia Versus Cardiovascular Disease Versus CRPFluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancyHigh-density lipoprotein particles may regulate hemostasis in human pregnancyLipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia
P50
Q27304699-EB3B4A23-F83C-458F-BA9F-D58B6B9C6B36Q30244919-8C518E5C-FF60-41A8-B2D0-F9D27E6107F7Q31143639-BF2C3FCD-60B2-4302-BB69-933814621A11Q31857986-2917CC57-82BB-4FB1-8356-FFB0F8D6FBB8Q33758710-7075D3C7-C68F-4A09-BE97-B522C82238A5Q34370899-8B4AD070-A957-4649-AD81-BAD4D758C055Q34561924-CADE8175-EB44-4D6E-BE3F-7F75A2A1BD1DQ36004768-1353849A-D903-4E18-9299-DAC73D8CF2CAQ37264749-B0FBFBCD-5E4C-4766-8242-57DCBB542E66Q38430192-C998A756-4325-490B-B941-180DEFAFF429Q39903413-196B49A7-68FB-49C4-826E-9471919EE752Q41716612-3E9807E6-7594-4F5E-8338-2FF754B1736EQ43257342-AB6E9065-8EC7-469D-95FB-788C91F9DDAFQ43975790-6640BA7A-9A03-409A-B407-E0BCDB944195Q43984141-61C20101-4EF9-457F-BD5F-9C958C9C7ADEQ44120778-1C939D66-BB4B-470B-A165-3D0251181C35Q44197998-CB0915D7-91EF-4A2E-9EDE-CA5632270A6FQ44700895-AC6348FB-1A11-42F7-A2EF-1F31878095EBQ44775544-F427E005-4C30-4AA5-98BC-212A650F0190Q44783499-E5879434-EA91-48A3-80A8-3A25AB54F042Q45142378-DD7EB614-0FB3-4324-9351-5691061F7446Q46211558-9ECB9DFF-7A52-46EC-8DC9-A427820A8642Q46218849-926F63F8-F2C1-4932-8023-24C4DED48CF9Q46528294-FD156A2B-E8E6-4814-A99F-68326A7E57C9Q46631895-FEFD4744-1BF2-4FFD-8315-E8F155232DBCQ46673242-86DB9BFC-B2DD-4210-9923-3FF4CAAC92F0Q47588154-EECD51F2-39BF-4538-A5D3-A74458444B35Q47701900-B83C94B3-D084-40F4-B4F7-C3B3F8983CA2Q50730560-00C92A71-4E9F-46FB-94E2-1504FCE8DE13Q51611505-7040F2F1-A466-45D0-AC72-25ECC78C00BAQ52563609-814DC159-89D5-4DB8-93B3-E0F1F98B5C70Q56991845-9CA9B7B8-87CE-455E-BEF1-C0874FCB2691Q58228805-A9C743E8-3101-4DDA-9A1E-9ED45781BEEBQ58228809-5B05CF4E-464E-4A7A-BF60-2B95CAB83406Q58835394-AB7D94DF-A0B7-46A9-92B1-E3E99A1CE127Q60176077-2CAA76DB-1184-401E-B5D8-78DF4DD74F5BQ60176130-96826C3C-E083-46E6-9612-58DDF569A408Q60176133-CCA112BF-E5B1-40F2-935C-3E98690014EBQ60176134-D700ECB9-B2F5-48AB-A8E4-3EF06A9CE17CQ60176143-2218F1E8-4419-4101-A854-817A6CEB9F83
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Irene Rebelo
@ast
Irene Rebelo
@bar
Irene Rebelo
@de
Irene Rebelo
@en
Irene Rebelo
@es
Irene Rebelo
@fr
Irene Rebelo
@nl
Irene Rebelo
@sl
type
label
Irene Rebelo
@ast
Irene Rebelo
@bar
Irene Rebelo
@de
Irene Rebelo
@en
Irene Rebelo
@es
Irene Rebelo
@fr
Irene Rebelo
@nl
Irene Rebelo
@sl
prefLabel
Irene Rebelo
@ast
Irene Rebelo
@bar
Irene Rebelo
@de
Irene Rebelo
@en
Irene Rebelo
@es
Irene Rebelo
@fr
Irene Rebelo
@nl
Irene Rebelo
@sl
P1053
K-4342-2013
P106
P1153
6701828822
P21
P31
P3829
P496
0000-0002-2330-7537